ABILIFY (aripiprazole) Effictive As Maintenance Therapy In Adults With Bipolar I Disorder Following Treatment For A  
Maintenance therapy with the Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. [click link for full article]